Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Sinobiopharma Announces Improved Q2

publication date: Jan 19, 2010
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Sinobiopharma reported greatly improved financial results for its Q2 (ended November 30, 2009). The company said revenues jumped 120% to $2.1 million and net income was $1.1 million, a $2.1 million increase from the year-earlier quarter. Sinobiopharma attributed the rise in revenue to continuing marketing of its major revenue driver, the muscle relaxant KuTai (cisatracurium besylate). More details..

Stock Symbol: (OTCBB: SNBP)



Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Alibaba IPO
Event Updates
Greg Scott will be attending and speaking at this event:
 
 
Hope to see you there!
 
ChinaBio® Events
 
China Forum 2014

Frankfurt, Germany
November 2, 2014

>> More events...

Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Sponsors